Evidence map›Paper›PMID 28497114›Full record

ArticlemSphere

Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR)

Brian M Luna, Amber Ulhaq, Jun Yan, Paul Pantapalangkoor, Travis B Nielsen, Bryan W Davies, Luis A Actis, Brad Spellberg

Abstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Novel Selectable Marker Sesquiterpenoid Antibiotic Pentalenolactone.International journal of molecular sciences · 2024
    Article
  5. The Comparative Characterization of a HypervirulentInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Genome diversity of domesticatedMicrobial genomics · 2022
    Article
  9. Insights intoFrontiers in immunology · 2022
    Review
  10. Pathogens (Basel, Switzerland) · 2021
    Review
  11. Recent Advances in Genetic Tools forFrontiers in genetics · 2020
    Review
  12. Article
  13. Article
  14. Next Generation of TnApplied and environmental microbiology · 2019
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Brian M LunaDepartment of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.ORCID 0000-0001-6718-4551
Amber UlhaqDepartment of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Jun YanDepartment of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Paul PantapalangkoorDepartment of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Travis B NielsenDepartment of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Bryan W DaviesDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
Luis A ActisDepartment of Microbiology, Miami University, Oxford, Ohio, USA.
Brad SpellbergDepartment of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.

Funding

MAb Passive Vaccination against Acinetobacter baumanniiR01AI130060 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRAD J SPELLBERG · 2017 to 2026
$6.7M
Transferrin Combination Therapy to Address Antimicrobial ResistanceR01AI117211 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SPELLBERG, BRAD J · 2016 to 2019
$2.7M
Diabetes and Inflammation During InfectionR21AI127954 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SPELLBERG, BRAD J · 2017 to 2018
$454k
NIAID NIH HHS R01 AI117211NIAID NIH HHS R01 AI130060NIAID NIH HHS R21 AI127954
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacterantibiotic resistancegeneticsGram-negative bacteriamolecular biology

Identifiers

PMID28497114
PMCPMC5422034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.